There is no website visitor data available for this stock.
---
LPCN FAQ
What was Lipocine’s price range in the past 12 months?
Lipocine lowest stock price was $2.31 and its highest was $5.97 in the past 12 months.
What is Lipocine’s market cap?
Currently, no data Available
When is Lipocine’s upcoming earnings report date?
Lipocine’s upcoming earnings report date is May 09, 2024 which is in 41 days.
How were Lipocine’s earnings last quarter?
Lipocine released its earnings results on Mar 07, 2024. The company reported -$0.51 earnings per share for the quarter, missing the consensus estimate of -$0.47 by -$0.04.
What happened to Lipocine’s price movement after its last earnings report?
Lipocine reported an EPS of -$0.51 in its last earnings report, missing expectations of -$0.47. Following the earnings report the stock price went up 1.397%.
Which hedge fund is a major shareholder of Lipocine?
Currently, no hedge funds are holding shares in LPCN
Lipocine, Inc. operates as a pharmaceutical company, which engages in the research and development of treatment for use in men's and women's health through proprietary drug delivery technologies. It focuses on the oral testosterone replacement therapy and preterm birth prevention. The company was founded in 2011 and is headquartered in Salt Lake City, UT.
Copying Matthew Kaplan's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -10.98% per trade.